zanamivir has been researched along with Leukemia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cordonnier, C; de la Camara, R; Engelhard, D; Ljungman, P; Mohty, B | 1 |
| Monto, AS; Whitley, RJ | 1 |
1 review(s) available for zanamivir and Leukemia
| Article | Year |
|---|---|
European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN.
Topics: Acetamides; Antiviral Agents; Hematopoietic Stem Cell Transplantation; Humans; Influenza, Human; Leukemia; Oseltamivir; Practice Guidelines as Topic; Zanamivir | 2013 |
1 other study(ies) available for zanamivir and Leukemia
| Article | Year |
|---|---|
Prevention and treatment of influenza in high-risk groups: children, pregnant women, immunocompromised hosts, and nursing home residents.
Topics: Adolescent; Adult; Aged; Animals; Child; Child, Preschool; Clinical Trials as Topic; Disease Outbreaks; Enzyme Inhibitors; Female; Homes for the Aged; Humans; Immunocompromised Host; Infant; Influenza Vaccines; Influenza, Human; Leukemia; Middle Aged; Nursing Homes; Oseltamivir; Pregnancy; Pregnancy Complications, Infectious; Rats; Risk; United States; Vaccination; Zanamivir | 2006 |